Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 7, 2009, Pages 914-920

  Guo, Y ^a,b,c   Zhou, Y ^d   Wang, C ^a,c   Zhu, L ^a,c   Wang, S ^d   Li, Q ^d   Jiang, G ^d   Zhao, B ^d   Huang, H ^d   Yu, H ^a,c   Xing, W ^a,b,c   Mitchelson, K ^a,b,c   Cheng, Jing ^a,b,c,e   Zhao, Yanlin ^d  

^a Tsinghua University   (China)

^b NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^c CapitalBio Corporation   (China)

^d DEPARTMENT OF HEALTH   (Hong Kong)

^e TSINGHUA UNIVERSITY   (China)

Author keywords

Biochip; MDR; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL PROTEIN; ISONIAZID; KATG PROTEIN; PROTEIN INHA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; BIOCHIP; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG SENSITIVITY; GENE MUTATION; HUMAN; HYBRIDIZATION; MEDICAL INSTRUMENTATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOSENSING TECHNIQUES; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 67651208029     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Goble M, Iseman M D, Madsen L A, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532. (Pubitemid 23053828)
2. Aziz M A, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-2154. (Pubitemid 44914009)
3. Bang D, Bengard Andersen A, Thomsen V O. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006; 44: 2605-2608. (Pubitemid 44092440)
4. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640. (Pubitemid 47295497)
5. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006; 44: 4459-4463. (Pubitemid 44940754)
6. Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol 2006; 44: 20-28. (Pubitemid 43100573)
7. Musser J M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
8. Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35: 719-723. (Pubitemid 27083868)
9. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230. (Pubitemid 24067929)
10. Leung E T, Ho P L, Yuen K Y, et al. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 2006; 50: 1075-1078. (Pubitemid 43328883)
11. Zhang M, Yue J, Yang Y P, et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2005; 43: 5477-5482. (Pubitemid 41612317)
12. Yue J, Shi W, Xie J, Li Y, Zeng E, Wang H. Mutations in the rpoB gene of multidrug-resisrant Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2003; 41: 2209-2212. (Pubitemid 36576568)
13. Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
14. Guo Y, Guo H, Zhang L, et al. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 2005; 79:14392-14403. (Pubitemid 41552736)
15. Zhu L X, Zhang Z W, Liang D, et al. Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob Agents Chemother 2007; 51: 3707-3713. (Pubitemid 47519362)
16. Zhu L X, Zhang Z W, Wang C, et al. Use of a DNA microarray for simultaneous detection of antibiotic resistance genes among staphylococcal clinical isolates. J Clin Microbiol 2007; 45: 3514-3521. (Pubitemid 350156841)
17. Williams D L, Spring L, Collins L, et al. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998; 42: 1853-1857. (Pubitemid 28311593)
18. Bobadilla-del-Valle M, Ponce-de-Leon A, Arenas-Huertero C, et al. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg Infect Dis 2001; 7: 1010-1013. (Pubitemid 33115782)
19. Park H, Song E J, Song E S, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 1619-1624. (Pubitemid 43726246)
20. Zhou Y M, Yang R Q, Tao S C, et al. The design and application of DNA chips for early detection of SARS-CoV from clinical samples. J Clin Virol 2005; 33: 123-131. (Pubitemid 40725306)
21. Makinen J, Marttila H J, Marjamaki M, Viljanen M K, Soini H. Comparison of two commercially available DNA line-probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-352. (Pubitemid 43222221)
22. Gryadunov D, Mikhailovich V, Lapa S, et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2005; 11: 531-539. (Pubitemid 40895152)
23. Kim S Y, Park Y J, Song E, et al. Evaluation of the CombiChip mycobacteria drug resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006; 54: 203-210. (Pubitemid 43319368)
24. Caoili J C, Mayorova A, Sikes D, Hickman L, Plikaytis B B, Shinnick T M. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 2378-2381. (Pubitemid 44092401)
25. Patterson T A, Lobenhofer E K, Fulmer-Smentek S B, et al. Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project. Nat Biotechnol 2006; 24: 1140-1150. (Pubitemid 44359726)
26. Shi L, Shi L, Reid L H, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24: 1151-1161. (Pubitemid 44359727)